The Down Syndrome in the face of Coronavirus infection
DOI:
https://doi.org/10.33448/rsd-v10i8.17355Keywords:
Coronavirus; Down Syndrome; COVID-19.; Coronavirus; Down syndrome; COVID-19.Abstract
This study aimed to elucidate how the genetic alterations caused by Down Syndrome (DS) impact cases of involvement by SARS-CoV-2, in addition to showing how social isolation can negatively affect the lives of individuals with DS. The study adopted the qualitative literary review model, through the Google Academic, SciELO and PubMed databases, using the descriptors “Down Syndrome” and “Coronavirus”, with twenty articles being selected. It was noticed that DS is the most common genetic form of intellectual disability and the changes that trisomy 21 cause significantly impact the disease course of people with DS infected with Coronavirus, since their immune system is overactivated, with ability to generate a shower of cytokines, which will facilitate the entry of the virus into cells, thus favoring viral replication. Furthermore, it was noted that, even though social isolation is effective in combating the pandemic, it can cause several damages to the health of the population with DS, which can aggravate certain pre-existing comorbidities in this group. Therefore, the surveillance and training of this population and their families is very important, so that they can correctly prevent themselves – with an effective hand washing technique and use of barrier equipment – minimizing exposure to the virus; and socialization and physical activity – even during quarantine periods and remotely – in order to preserve the emotional and physical health of these individuals
References
Aquino, E. M. L., Silveira, I. H., Pescarini, J. M., Aquino, R., Souza-Filho, J. A. de, Rocha, A. dos S., Ferreira, A., Victor, A., Teixeira, C., Machado, D. B., Paixão, E., Alves, F. J. O., Pilecco, F., Menezes, G., Gabrielli, L., Leite, L., Almeida, M. da C. C. de, Ortelan, N., Fernandes, Q. H. R. F., & Ortiz, R. J. F. (2020). Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Ciência & Saúde Coletiva, 25(suppl 1), 2423–2446. https://doi.org/10.1590/1413-81232020256.1.10502020
Clift, A. K., Coupland, C. A. C., Keogh, R. H., Hemingway, H., & Hippisley-Cox, J. (2021). COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults. Annals of Internal Medicine, 174(4), 572–576. https://doi.org/10.7326/m20-4986
Correia, B. F., Saraiva, J. F. K., Mayeiro, M. G. de C., Soldá, M. V., Baraldi, N. R., Bustamante, T. F. O., & Aguiar, V. B. (2020). Protagonismo de jovens com Síndrome de Down em campanha de prevenção ao SARS-CoV-2. Gestão E Desenvolvimento, (28), 301-313. https://doi.org/10.34632/gestaoedesenvolvimento.2020.9474
De Cauwer, H., & Spaepen, A. (2020). Are patients with Down syndrome vulnerable to life-threatening COVID-19? Acta Neurologica Belgica, 121(3), 685–687. https://doi.org/10.1007/s13760-020-01373-8
De Toma, I., & Dierssen, M. (2021). Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-81451-w
Del Carmen Ortega, M., Borrel, J. M., de Jesús Bermejo, T., González-Lamuño, D., Manso, C., de la Torre, R., Mayer, M.-A., de Asúa, D. R., & Dierssen, M. (2020). Lessons from individuals with Down syndrome during COVID-19. The Lancet Neurology, 19(12), 974–975. https://doi.org/10.1016/s1474-4422(20)30401-4
Emami, A., Javanmardi, F., Akbari, A., & Asadi-Pooya, A. A. (2021). COVID-19 in patients with Down syndrome. Neurological Sciences, 42(5), 1649–1652. https://doi.org/10.1007/s10072-021-05091-8
Espinosa, J. M. (2020). Down Syndrome and COVID-19: A Perfect Storm? Cell Reports Medicine, 1(2), 100019. https://doi.org/10.1016/j.xcrm.2020.100019
Faundes, V., Pardo, R., Cammarata-Scalisi, F., Alarcon, P., Lay-Son, G., Martin, S., Faundes, V., Pardo, R., Cammarata-Scalisi, F., Alarcon, P., Lay-Son, G., & Martin, S. (2021). Consenso de la Rama de Genética de la Sociedad Chilena de Pediatría sobre priorización de personas con Síndrome de Down y otras condiciones poco frecuentes en la Campaña de Vacunación COVID-19. Andes Pediatrica, 92(2), 309–315. https://doi.org/10.32641/andespediatr.v92i2.3716
Figueiredo Filho, D. B., & Silva, L. E. de O. (2021). Social distancing and severe acute respiratory syndrome coronavirus 2 transmission: A case study from Araraquara, São Paulo, Brazil. Revista Da Sociedade Brasileira de Medicina Tropical, 54. https://doi.org/10.1590/0037-8682-0197-2021
Kantar, A., Mazza, A., Bonanomi, E., Odoni, M., Seminara, M., Verde, I. D., Lovati, C., Bolognini, S., & D’Antiga, L. (2020). COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course. BMC Pediatrics, 20(1). https://doi.org/10.1186/s12887-020-02471-5
Kim-Hellmuth, S., Hermann, M., Eilenberger, J., Ley-Zaporozhan, J., Fischer, M., Hauck, F., Klein, C., Haas, N., Kappler, M., Huebner, J., Jakob, A., & von Both, U. (2020). SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome. Journal of the Pediatric Infectious Diseases Society, 10(4), 543–546. https://doi.org/10.1093/jpids/piaa148
Krishnan, U. S., Krishnan, S. S., Jain, S., Chavolla-Calderon, M. B., Lewis, M., Chung, W. K., & Rosenzweig, E. B. (2020). SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor? The Journal of Pediatrics, 225, 246–248. https://doi.org/10.1016/j.jpeds.2020.06.076
Marques, A. C., Silveira, N. R., Ramson, B. P., Krüger, G. R., & Silveira, J. R. (2020). Ações Do Projeto Carinho Durante O Isolamento Social Ocasionado Pela Covid-19: Grupo Downdança. Expressa Extensão, 26(1), 154–162. https://doi.org/10.15210/ee.v26i1.19658
Newman, A. M., Jhaveri, R., Patel, A. B., Tan, T. Q., Toia, J. M., & Arshad, M. (2021). Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients. The Journal of Pediatrics, 228, 294–296. https://doi.org/10.1016/j.jpeds.2020.08.067
Olsen, M. B. (2020). Downs syndrom og covid-19 – en oversett risikogruppe? Tidsskrift for Den Norske Legeforening. https://doi.org/10.4045/tidsskr.20.0754
Paz-Maldonado, E. (2021). Síndrome de Down y COVID-19: Una Breve Perspectiva. Revista Ecuatoriana de Neurologia, 30(1), 15–15. https://doi.org/10.46997/revecuatneurol30100015
Russo, G. C., Bernardes, N., Baraldi, N. R., Saraiva, D. J. B., Angelis, K. D., Lantieri, C. J. B., & Saraiva, J. F. (2020). Ações contra a Covid-19 na População com Síndrome de Down. Arquivos Brasileiros de Cardiologia, 115(5), 939–941. https://doi.org/10.36660/abc.20200685
Santoro, S. L., Chicoine, B., Jasien, J. M., Kim, J. L., Stephens, M., Bulova, P., & Capone, G. (2020). Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature. American Journal of Medical Genetics Part A, 185(1), 286–299. https://doi.org/10.1002/ajmg.a.61924
Soares, A., Dorlivete, P., Shitsuka, M., Parreira, F., & Shitsuka, R. (2018). Metodologia Da Pesquisa Científica. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1
Silva, L. T., Meurer, N. C., Rodrigues, D. A. C., Rahal, Y. A., Souza, I. A. de, Caran, L. L., Cruz, I. M., Romera, L. de O., Almeida, L. B. de, Ribeiro, I. P. de A., Nunes, T. D. A., Ferracini, G. F., Polizeli, L. B., Gonçalves, F., & Gonçalves, F. da S. (2021). Gestação e pandemia da COVID-19: Impactos no binômio materno-fetal. Research, Society and Development, 10(7), e23510716416. https://doi.org/10.33448/rsd-v10i7.16416
Vita, S., Di Bari, V., Corpolongo, A., Goletti, D., Espinosa, J., Petracca, S., Palmieri, F., Nicastri, E., Abbonizio, Agrati, C., Albarello, F., Amadei, G., Amendola, A., Antonini, M., Barbaro, R., Bartolini, B., Benigni, M., Bevilacqua, N., Bordi, L., & Bordoni, V. (2021). Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome. International Journal of Infectious Diseases, 103, 607–610. https://doi.org/10.1016/j.ijid.2020.11.188
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Larissa Távore Silva; João Pedro Granado Leme Nunes; Alex Gomes de França; Alexandre Silva Zacarias ; Yasmin Abou Rahal; Gabriela Andrade Roversi; Beatriz Barboza Garavaso; Larissa Barros de Almeida; Maria Julia Escame Romano; Adriani Monisi Visoná; Julia Coradini Virgili; Isabella Cavalari Barboza; Yanca Lucrécia Moreira Schmidt; Fábio Gonçalves; Elenberg Chaves de Paula
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
